Could a cancer drug boost social abilities in rare genetic disorder?
NCT ID NCT07218575
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 23 times
Summary
This study tests whether everolimus, a drug already approved for other conditions, can safely improve social abilities in people with PTEN Hamartoma Tumor Syndrome (PHTS). About 60 adults and children with social difficulties will take either everolimus or a placebo for 6 months, then all will receive the drug for another 6 months. The goal is to see if social skills get better without serious side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COWDEN'S DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.